- Corporate Officers - A
- Arkin Moshe
Insider Trading History of Arkin Moshe
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Arkin Moshe since 2008.
This trader's CIK number is 1321178.
At the time of last reporting, Arkin Moshe was the 10% Owner of Werewolf Therapeutics, Inc.. (stock ticker symbol HOWL).
Also see all insider trading activities at Werewolf Therapeutics, Inc..
Note that in the past
Arkin Moshe also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Perrigo Co (PRGO) by Arkin Moshe
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | PRGO | 0 | $0 | 1,860,121 | $154,950,901 | 34,513 | $860,961 |
| 2010 | PRGO | 0 | $0 | 0 | $0 | 6,146 | $0 |
| 2009 | PRGO | 0 | $0 | 299,142 | $10,201,698 | 55,000 | $829,400 |
| 2008 | PRGO | 0 | $0 | 3,000,126 | $134,937,283 | 0 | $0 |
Yearly summary of insider trading at Werewolf Therapeutics, Inc. (HOWL) by Arkin Moshe
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | HOWL | 400,000 | $6,400,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Keros Therapeutics, Inc. (KROS) by Arkin Moshe
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | KROS | 120,000 | $1,920,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ophthalmic Imaging Systems (OISI) by Arkin Moshe
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | OISI | 3,581,089 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neurogesx Inc (NGSX) by Arkin Moshe
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | NGSX | 30,000 | $165,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Arkin Moshe:
1. Perrigo Co (PRGO)
2. Werewolf Therapeutics, Inc. (HOWL)
3. Keros Therapeutics, Inc. (KROS)
4. Ophthalmic Imaging Systems (OISI)
5. Neurogesx Inc (NGSX)
Table 1. Insider trading of Perrigo Co (PRGO) by Arkin Moshe
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-08-31 | PRGO | Sale | 79,855 | 95.31 | 7,610,980 |
| 2011-08-30 | PRGO | Sale | 170,145 | 96.46 | 16,411,846 |
| 2011-05-20 | PRGO | Sale | 400 | 87.00 | 34,800 |
| 2011-05-19 | PRGO | Sale | 37,557 | 87.04 | 3,268,998 |
| 2011-05-18 | PRGO | Sale | 142,805 | 86.31 | 12,325,927 |
| 2011-05-13 | PRGO | Sale | 7,195 | 87.78 | 631,591 |
| 2011-05-12 | PRGO | Sale | 100,000 | 87.43 | 8,742,600 |
| 2011-05-10 | PRGO | Sale | 78,553 | 87.52 | 6,874,644 |
| 2011-05-11 | PRGO | Sale | 50,175 | 87.24 | 4,377,317 |
| 2011-05-06 | PRGO | Sale | 65,095 | 87.43 | 5,691,125 |
| 2011-05-09 | PRGO | Sale | 141,127 | 87.63 | 12,366,535 |
| 2011-05-05 | PRGO | Sale | 165,050 | 86.03 | 14,199,581 |
| 2011-03-02 | PRGO | Sale | 77,901 | 76.67 | 5,972,513 |
| 2011-03-03 | PRGO | Sale | 22,099 | 77.38 | 1,709,976 |
| 2011-02-28 | PRGO | Option Ex | 34,513 | 24.95 | 860,961 |
| 2011-03-01 | PRGO | Sale | 50,000 | 76.77 | 3,838,550 |
| 2011-02-28 | PRGO | Sale | 84,513 | 76.18 | 6,437,862 |
| 2011-02-25 | PRGO | Sale | 43,874 | 75.55 | 3,314,549 |
| 2011-02-22 | PRGO | Sale | 56,126 | 74.94 | 4,205,801 |
| 2011-02-18 | PRGO | Sale | 200,000 | 75.69 | 15,138,399 |
| 2011-02-16 | PRGO | Sale | 200,000 | 75.66 | 15,131,800 |
| 2011-02-17 | PRGO | Sale | 87,651 | 76.05 | 6,665,507 |
| 2010-08-30 | PRGO | Option Ex | 6,146 | .00 | 0 |
| 2009-12-03 | PRGO | Option Ex | 55,000 | 15.08 | 829,400 |
| 2009-10-05 | PRGO | Sale | 27,516 | 34.01 | 935,764 |
| 2009-10-01 | PRGO | Sale | 234,890 | 34.13 | 8,015,856 |
| 2009-09-29 | PRGO | Sale | 28,494 | 34.04 | 969,850 |
| 2009-09-30 | PRGO | Sale | 8,242 | 34.00 | 280,228 |
| 2008-11-28 | PRGO | Sale | 160,000 | 34.35 | 5,495,839 |
| 2008-11-26 | PRGO | Sale | 56,900 | 34.01 | 1,934,884 |
| 2008-11-25 | PRGO | Sale | 20,000 | 34.07 | 681,420 |
| 2008-11-14 | PRGO | Sale | 60,000 | 34.07 | 2,044,140 |
| 2008-11-13 | PRGO | Sale | 20,000 | 34.01 | 680,100 |
| 2008-11-04 | PRGO | Sale | 68,200 | 34.83 | 2,375,133 |
| 2008-10-31 | PRGO | Sale | 135,500 | 34.25 | 4,640,875 |
| 2008-11-03 | PRGO | Sale | 160,100 | 34.53 | 5,528,893 |
| 2008-10-30 | PRGO | Sale | 8,566 | 34.01 | 291,295 |
| 2008-10-16 | PRGO | Sale | 28,400 | 34.04 | 966,707 |
| 2008-10-15 | PRGO | Sale | 26,635 | 34.57 | 920,692 |
| 2008-10-14 | PRGO | Sale | 230,000 | 35.30 | 8,120,150 |
| 2008-10-13 | PRGO | Sale | 220,000 | 34.34 | 7,555,680 |
| 2008-10-09 | PRGO | Sale | 29,187 | 34.33 | 1,002,077 |
| 2008-10-09 | PRGO | Sale | 56,200 | 35.10 | 1,972,788 |
| 2008-10-08 | PRGO | Sale | 43,789 | 34.25 | 1,499,817 |
| 2008-10-08 | PRGO | Sale | 22,189 | 34.51 | 765,698 |
| 2008-10-08 | PRGO | Sale | 15,262 | 34.55 | 527,332 |
| 2008-10-09 | PRGO | Sale | 24,613 | 34.05 | 838,023 |
| 2008-10-08 | PRGO | Sale | 9,600 | 35.27 | 338,592 |
| 2008-10-08 | PRGO | Sale | 16,187 | 35.03 | 567,062 |
| 2008-10-08 | PRGO | Sale | 25,947 | 34.81 | 903,163 |
| 2008-10-08 | PRGO | Sale | 30,864 | 34.72 | 1,071,659 |
| 2008-10-08 | PRGO | Sale | 25,562 | 34.63 | 885,212 |
| 2008-10-06 | PRGO | Sale | 17,000 | 35.16 | 597,737 |
| 2008-10-06 | PRGO | Sale | 13,685 | 35.60 | 487,186 |
| 2008-10-06 | PRGO | Sale | 3,500 | 36.72 | 128,502 |
| 2008-10-07 | PRGO | Sale | 10,100 | 35.24 | 355,974 |
| 2008-10-07 | PRGO | Sale | 32,630 | 35.32 | 1,152,491 |
| 2008-10-07 | PRGO | Sale | 17,127 | 35.51 | 608,179 |
| 2008-10-07 | PRGO | Sale | 18,443 | 1,652.19 | 30,471,395 |
| 2008-10-07 | PRGO | Sale | 40,699 | 35.71 | 1,453,401 |
| 2008-10-07 | PRGO | Sale | 19,806 | 35.77 | 708,460 |
| 2008-10-07 | PRGO | Sale | 20,300 | 35.84 | 727,491 |
| 2008-10-06 | PRGO | Sale | 27,915 | 35.05 | 978,364 |
| 2008-10-06 | PRGO | Sale | 21,200 | 34.93 | 740,473 |
| 2008-10-07 | PRGO | Sale | 24,916 | 35.91 | 894,608 |
| 2008-10-07 | PRGO | Sale | 64,179 | 35.98 | 2,309,417 |
| 2008-10-07 | PRGO | Sale | 14,500 | 36.03 | 522,493 |
| 2008-10-07 | PRGO | Sale | 26,270 | 36.10 | 948,399 |
| 2008-10-07 | PRGO | Sale | 5,500 | 36.23 | 199,270 |
| 2008-10-07 | PRGO | Sale | 15,530 | 36.15 | 561,331 |
| 2008-10-06 | PRGO | Sale | 22,800 | 34.31 | 782,336 |
| 2008-10-06 | PRGO | Sale | 11,100 | 34.61 | 384,126 |
| 2008-10-06 | PRGO | Sale | 17,300 | 34.70 | 600,361 |
| 2008-10-06 | PRGO | Sale | 15,500 | 34.77 | 538,997 |
| 2008-09-05 | PRGO | Sale | 3,837 | 34.80 | 133,527 |
| 2008-09-03 | PRGO | Sale | 400 | 34.97 | 13,988 |
| 2008-09-03 | PRGO | Sale | 95,545 | 34.92 | 3,336,526 |
| 2008-08-25 | PRGO | Sale | 17,893 | 36.13 | 646,545 |
| 2008-08-22 | PRGO | Sale | 56,000 | 36.48 | 2,043,160 |
| 2008-08-22 | PRGO | Sale | 44,000 | 36.28 | 1,596,496 |
| 2008-08-21 | PRGO | Sale | 50,060 | 35.56 | 1,779,983 |
| 2008-08-21 | PRGO | Sale | 87,264 | 35.95 | 3,137,577 |
| 2008-08-21 | PRGO | Sale | 119,563 | 35.75 | 4,274,496 |
| 2008-08-20 | PRGO | Sale | 43,113 | 35.57 | 1,533,443 |
| 2008-02-26 | PRGO | Sale | 45,900 | 35.57 | 1,632,663 |
| 2008-02-02 | PRGO | Sale | 1,200 | 35.22 | 42,264 |
| 2008-02-26 | PRGO | Sale | 61,726 | 35.28 | 2,178,001 |
| 2008-02-06 | PRGO | Sale | 900 | 35.11 | 31,599 |
| 2008-02-26 | PRGO | Sale | 40,274 | 35.07 | 1,412,288 |
| 2008-02-25 | PRGO | Sale | 31,461 | 35.56 | 1,118,658 |
| 2008-02-25 | PRGO | Sale | 206,039 | 35.34 | 7,280,800 |
| 2008-02-21 | PRGO | Sale | 44,933 | 35.04 | 1,574,632 |
| 2008-02-19 | PRGO | Sale | 94,767 | 35.42 | 3,357,026 |
| 2008-02-19 | PRGO | Sale | 1,550 | 35.73 | 55,389 |
Table 2. Insider trading of Werewolf Therapeutics, Inc. (HOWL) by Arkin Moshe
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-05-04 | HOWL | Buy | 400,000 | 16.00 | 6,400,000 |
Table 3. Insider trading of Keros Therapeutics, Inc. (KROS) by Arkin Moshe
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-04-13 | KROS | Buy | 120,000 | 16.00 | 1,920,000 |
Table 4. Insider trading of Ophthalmic Imaging Systems (OISI) by Arkin Moshe
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-05-26 | OISI | Buy | 3,581,089 | .00 | 0 |
Table 5. Insider trading of Neurogesx Inc (NGSX) by Arkin Moshe
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-09-09 | NGSX | Buy | 30,000 | 5.50 | 165,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Arkin Moshe
(10% Owner of Werewolf Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.